Decibel Therapeutics is a biotech company that develops treatments for hearing and balance disorders. The company's product candidates include Gene Therapies for Congenital, Monogenic Hearing Loss, Gene Therapies for Hair Cell Regeneration, and Otoprotection Therapeutic for preventing hearing loss in cancer patients. Decibel Therapeutics is collaborating with Regeneron Pharmaceuticals and has headquarters in Boston, Massachusetts.